Literature DB >> 9829875

Estimation of the incidence of Lyme disease.

G L Campbell1, C L Fritz, D Fish, J Nowakowski, R B Nadelman, G P Wormser.   

Abstract

The incidence of Lyme disease in most endemic areas is unknown but will be an important factor in determining the cost-effectiveness of Lyme disease vaccines in those areas. The authors developed a deterministic model with nine components to estimate the frequency of Ixodes scapularis tick bites and the resulting incidence of Lyme disease in residents of endemic areas. For each component, best point estimates and plausible ranges of values were based on the published literature, unpublished data, expert opinion, or a combination of the above. By using the mean, crude, annual total of 3,827 Lyme disease cases reported from the endemic county of Westchester, New York, in 1991-1994, a mean of 178,889 I. scapularis bites (20.4 per 100 person-years) and a mean of 10,632 incident Lyme disease cases (1.2 per 100 person-years) were estimated to have occurred per year. Results of a sensitivity analysis that used two different methods suggested that this deterministic model is reasonably robust. In conclusion, according to this model, the incidence of Lyme disease in Westchester County is several-fold higher than suggested by the current passive reporting system.

Entities:  

Mesh:

Year:  1998        PMID: 9829875     DOI: 10.1093/oxfordjournals.aje.a009568

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  16 in total

1.  Lyme borreliosis in Ontario: determining the risks.

Authors:  I K Barker; L R Lindsay
Journal:  CMAJ       Date:  2000-05-30       Impact factor: 8.262

2.  Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state.

Authors:  John M Boltri; Robert B Hash; Robert L Vogel
Journal:  J Community Health       Date:  2002-12

3.  Characterization of Borrelia burgdorferi BlyA and BlyB proteins: a prophage-encoded holin-like system.

Authors:  C J Damman; C H Eggers; D S Samuels; D B Oliver
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

4.  Paradigm Burgenland: risk of Borrelia burgdorferi sensu lato infection indicated by variable seroprevalence rates in hunters.

Authors:  Emel Cetin; Mahtab Sotoudeh; Herbert Auer; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

Review 5.  Updates on Borrelia burgdorferi sensu lato complex with respect to public health.

Authors:  Nataliia Rudenko; Maryna Golovchenko; Libor Grubhoffer; James H Oliver
Journal:  Ticks Tick Borne Dis       Date:  2011-05-27       Impact factor: 3.744

6.  Critical Evaluation of the Linkage Between Tick-Based Risk Measures and the Occurrence of Lyme Disease Cases.

Authors:  Lars Eisen; Rebecca J Eisen
Journal:  J Med Entomol       Date:  2016-09-01       Impact factor: 2.278

7.  Simple objective detection of human lyme disease infection using immuno-PCR and a single recombinant hybrid antigen.

Authors:  Micah D Halpern; Claudia R Molins; Martin Schriefer; Mollie W Jewett
Journal:  Clin Vaccine Immunol       Date:  2014-06-04

8.  Detection of Borrelia burgdorferi sensu stricto ospC alleles associated with human lyme borreliosis worldwide in non-human-biting tick Ixodes affinis and rodent hosts in Southeastern United States.

Authors:  Nataliia Rudenko; Maryna Golovchenko; Václav Hönig; Nadja Mallátová; Lenka Krbková; Peter Mikulásek; Natalia Fedorova; Natalia M Belfiore; Libor Grubhoffer; Robert S Lane; James H Oliver
Journal:  Appl Environ Microbiol       Date:  2012-12-21       Impact factor: 4.792

Review 9.  Control of ixodid ticks and prevention of tick-borne diseases in the United States: The prospect of a new Lyme disease vaccine and the continuing problem with tick exposure on residential properties.

Authors:  Lars Eisen
Journal:  Ticks Tick Borne Dis       Date:  2021-01-20       Impact factor: 3.744

10.  Hypersensitivity to ticks and Lyme disease risk.

Authors:  Georgine Burke; Stephen K Wikel; Andrew Spielman; Sam R Telford; Kathleen McKay; Peter J Krause
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.